In 2017, the National Committee established a Track II dialogue between the United States and China to discuss issues surrounding healthcare faced by both nations, in partnership with the National School of Development (NSD) at Peking University. Under the theme, “Providing Effective Healthcare,” this ongoing annual dialogue examines the effectiveness of the healthcare systems in China and the United States and recommends ways to better measure and manage the delivery and efficiency of healthcare in the two countries. In addressing the topic, participants consider the current plans of and challenges facing both nations, including, in the case of China, the proposals for “Healthy China” set out in the 13th Five-Year Plan, and, in the case of the United States, ongoing changes to the healthcare system.

The U.S. team is led by Dr. Mark McClellan, former commissioner of the U.S. Food and Drug Administration and director and Robert J. Margolis, professor of business, medicine and health policy at the Margolis Center for Health Policy, Duke University. The leader of the Chinese delegation is Dr. Liu Qian, former vice minister of the Ministry of Health. Heading the NSD’s efforts is Dr. Gordon Liu, BOYA distinguished professor of NSD at PKU.